Section Editor
- Mary J Laughlin, Division of Hematology/Oncology, University of Virginia
- Dan L Longo, National Institute on Aging, National Institutes of Health
Executive Editor
- Peter O'Donovan, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Hematology 2013, 13:2An interview with Dan L Longo
Section Editor Dan L Longo relates how he first became interested in hematology and gives his personal view on the recent progress and future challenges of the hematological cancer field in particular.
-
BMC Hematology 2013, 13:1Evolving along with the hematology field
This Editorial discusses the rationale behind the launch of BMC Hematology, formerly known as BMC Blood Disorders, within the BMC series of journals published by BioMed Central.
- View more articles
News from the web
- 02 October 2013
- Study demonstrates significant clinical and economic impact of Nanosphere's Verigene blood culture test
- 02 October 2013
- Compound developed that may treat erectile dysfunction priapism
Scope
BMC Hematology is an open access, peer-reviewed journal that considers articles on basic, experimental and clinical research related to hematology. The journal welcomes submissions on non-malignant and malignant hematological diseases, hemostasis and thrombosis, hematopoiesis, stem cells and transplantation.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Hematology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmchematol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
Section Editor's profile
Dan L. Longo
Dr. Longo is Professor of Medicine at Harvard Medical School in the Division of Hematology at Brigham and Women's Hospital and Deputy Editor of the New England Journal of Medicine. He is a Master of the American College of Physicians and is a member of the American Society of Clinical Investigation and the Association of American Physicians.
He has been active in research on the treatment of malignant lymphoma including new treatments targeting CD30, CD40, HLA Class II molecules and immunoglobulin idiotype. His laboratory work has focused in part on the regulation of lymphocyte proliferation, NK cell effects on hematopoiesis, and tumor-induced immunosuppression.
Dan Longo is the Section Editor of the Malignant hematological diseases section of BMC Hematology. Read more about the key issues in this field and the manuscripts he would like to see submitted to the section in his interview with the journal.
BMC series blog
- 25 September 2013
- BMC and the Royal College of General Practitioners
- 19 September 2013
- Enhancing sexual health services through E-health technology
BMC Blood Disorders
BMC Hematology assimilated the Editorial board and history of BMC Blood Disorders on renaming of the journal in 2013. The full archive of BMC Blood Disorders is available here and the rationale and objectives behind the change of journal name are explained in the editorial that accompanied the relaunch.
Email updates
Receive periodic news and updates relating to BioMed Central straight to your inbox.
